Overview
Eppendorf develops and sells lab equipment used in life sciences. Its product range includes precision liquid handling tools (notably the piston-stroke pipette), sample containers (like the Eppi tube) and centrifugation systems. The pipette measures small liquid volumes by translating a piston stroke into a controlled displacement, while tubes store samples and centrifuges separate components by spinning samples at high speed; these pieces form the Microliter System that underpins many molecular biology workflows. The company differentiates itself through a long, privately held lineage with a history of building essential lab tools, a broad and integrated ecosystem of high‑quality instruments (from basic pipetting to premium centrifuges), and a focus on reliability for professional labs. Its goal is to remain a leading provider of precise, durable laboratory equipment that supports researchers and bioprocess work worldwide.
Work here?Claim your company
Simplify's take
What believers are saying
- Eppendorf expects low single-digit revenue growth in 2026, despite market volatility.
- The November 12, 2026 Penang factory start expands capacity and regional cost advantages.
- DKSH Thailand outsourcing and 2025 restructuring already lifted EBIT margin to 10.3%.
What critics are saying
- Revenue fell to €924 million in 2025, exposing weak demand and pricing pressure.
- Thermo Fisher’s 2025-2026 centrifuge and tip expansion compresses Eppendorf’s premium hardware margins.
- Malaysia production starts in 2027; execution delays would weaken the 2030 network reset.
What makes Eppendorf unique
- Eppendorf’s 2026 pipette and centrifuge refreshes lock workflows into installed laboratory bases.
- Research 3 neo, SpinPro 8 R, and 5811 R reinforce premium sample-handling breadth.
- Biobased consumables and LoBind chemistry differentiate Eppendorf on reproducibility and sustainability.
Help us improve and share your feedback! Did you find this helpful?